Healthy volunteers test new drug delivery methods
NCT ID NCT05721989
First seen Jan 11, 2026 · Last updated May 16, 2026 · Updated 18 times
Summary
This study looked at how quickly and completely the experimental drug ziltivekimab enters the body when given as a shot under the skin. Researchers compared three different versions of the drug and two injection methods—a regular syringe and a pen-injector. A total of 267 healthy adults took part to help understand the drug's safety and how it moves through the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ICON - location Groningen
Groningen, 9728 NZ, Netherlands
-
ICON Budapest Phase I Unit
Budapest, 1077, Hungary
Conditions
Explore the condition pages connected to this study.